Oral fluoroquinolones for maintenance treatment of melioidosis (Q34456128)

2 August 2017

title

Oral fluoroquinolones for maintenance treatment of melioidosis (English)

1 reference

2 August 2017

0 references

4

White NJ

1 reference

2 August 2017

Chaowagul W

1

1 reference

2 August 2017

Suputtamongkul Y

series ordinal

2

1 reference

2 August 2017

Smith MD

series ordinal

3

1 reference

2 August 2017

publication date

1 September 1997

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

2 August 2017

published in

1 reference

2 August 2017

volume

91

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

599-601

1 reference

Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminoglycoside antibiotics

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

Survival of Pseudomonas pseudomallei in human phagocytes

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

Amoxycillin-clavulanic acid treatment of melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment

1 reference

https://api.crossref.org/works/10.1016/S0035-9203(97)90044-4

7 January 2021

10.1016/S0035-9203(97)90044-4

Identifiers

DOI

1 reference

2 August 2017

1 reference